Immage Biotherapeutics CorpOver The Counter Market:IMMG
- LAST PRICE0.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 0.0000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Immage Biotherapeutics Corp | 150.0 | 0.0x | --- |
Makamer Holdings Inc | 40.0 | 0.0x | --- |
Plastec Technologies Ltd | 258.8K | -30.8x | --- |
Flameret Inc | 299.6K | 1.7x | --- |
Eurotech Ltd | 4.4K | 0.0x | --- |
Plastic2Oil Inc | 562.7K | -0.2x | --- |
Company Information
Immage Biotherapeutics Corp. is a biotechnology company. The Company is engaged in developing cancer immunotherapy through development of cutting-edge immunotherapy candidates using bioinformatics and outsourced laboratory resources. It is focused on developing immunotherapy biologics to treat various cancers. The Company develops, markets and licenses its immunotherapy candidate for melanoma-associated antigen-A (MAGE A). The Company plans to focus on the development of immunotherapy for breast and prostate cancer. The Company focuses on developing a fusion/hybrid antigen cancer vaccine that would not only be human leukocyte antigen (HLA) free, but also be effective to all the isomers associated with MAGE A, from 1 to 11, and the identification and development of immunotherapy candidates from its intellectual property library for the preparation for human clinical trials using a viral vector construct.
Contact Information
- Headquarters
- 10411 Motor City Dr Ste 750BETHESDA, MD, United States 20817-1289
- Phone
- 443-961-1185
- Fax
- ---
Executives
- Chairman of the Board, Chief Scientific Officer
- Anton Dormer
- President, Treasurer, Secretary, Director
- Zhi Cong Mou
- Chief Financial Officer, Director
- Elton Norman
- Chief Operating Officer, Director
- Mahesh Narayanan
- Vice President - Bioformatics
- Daniel Achinko
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $150.00 |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 151.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.01 |
Book Value | $0.00 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
